MedTrace Logo

Vasovist Endoleak Study

NCT00483665 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2008-11-19

No results posted yet for this study

Summary

After endovascular treatment of an abdominal aortic aneurysm, lifelong imaging follow-up is needed to monitor the effectiveness of the treatment. One parameter in this follow-up is endoleak, which is leakage of blood into the aneurysm sac. The aim of this study is to investigate the value of magnetic resonance imaging using Vasovist as a contrast agent for the detection of endoleaks.

Conditions

  • Abdominal Aortic Aneurysm

Interventions

PROCEDURE

Computed tomography angiography

Computed tomography angiography

PROCEDURE

Magnetic resonance imaging

Magnetic resonance imaging after injection of Vasovist

Sponsors & Collaborators

  • Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

    collaborator INDUSTRY

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Mathias Prokop, MD PhD · UMC Utrecht

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00483665 on ClinicalTrials.gov